Mark Kester

Kester, Mark

Primary Appointment

Professor, Pharmacology


  • PhD, , State University of New York at Buffalo
  • Postdoc, , University of Illinois, Chicago

Contact Information

P.O. Box 800334
Cancer Center, Room 6171-H
Charlottesville, VA 22908
Telephone: 434-243-2645
Fax: 434-243-8058

Research Disciplines

Biochemistry, Biotechnology, Cancer Biology, Cardiovascular Biology, Epigenetics, Experimental Pathology, Immunology, Infectious Diseases/Biodefense, Metabolism, Molecular Biology, Molecular Pharmacology, Structural Biology, Translational Science

Research Interests

Nanotechnologies for targeted drug delivery

Research Description

Dr. Kester has research interests that include the design, characterization and validation of nanotechnologies for targeted drug delivery. His laboratory has evaluated nanoliposomes, nanodendrimers and nanocolloids as effective drug delivery vehicles for pharmacological and molecular agents. Recent work focuses on nontoxic nanoscale systemic delivery systems for hydrophobic pro-apoptotic lipids as well as siRNAs that target mutated tumorigenic proteins. Dr. Kester has consulted with, or helped found, several companies that have the license to his "nano Solutions". In addition, Dr.Kester is a co-author of Integrated Pharmacology, published by Elsevier, Ltd., which was just recognized as a "highly commended textbook" by the British Medical Society.

Selected Publications